Acorah Software Products - Accounts Production 19.3.550 false true false true No description of principal activity 29 October 2024 31 October 2025 31 October 2025 16047243 Dr Stasa Stankovic iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16047243 2024-10-28 16047243 2025-10-31 16047243 2024-10-29 2025-10-31 16047243 frs-core:CurrentFinancialInstruments 2025-10-31 16047243 frs-bus:PrivateLimitedCompanyLtd 2024-10-29 2025-10-31 16047243 frs-bus:FilletedAccounts 2024-10-29 2025-10-31 16047243 frs-bus:Micro-entities 2024-10-29 2025-10-31 16047243 frs-bus:AuditExempt-NoAccountantsReport 2024-10-29 2025-10-31 16047243 frs-bus:Director1 2024-10-29 2025-10-31
Registered number: 16047243
Epona Healthcare Partners Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2025
Wilson Partners Ltd
Ketton Suite The King Centre, Main Road
Barleythorpe
Oakham
LE15 7WD
Balance Sheet
Registered number: 16047243
2025
£
Current assets 13,306
Creditors: Amounts Falling Due Within One Year (3,677 )
NET CURRENT ASSETS 9,629
TOTAL ASSETS LESS CURRENT LIABILITIES 9,629
NET ASSETS 9,629
CAPITAL AND RESERVES 9,629

Notes

1. General Information
Epona Healthcare Partners Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16047243 . The registered office is Flat D, 1st Floor, 23 York Street, London, W1U 6PF.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Stasa Stankovic
Director
28 July 2026